Daytime Sleepiness and Insomnia Linked to Increased Hypertension Risk: New Research Insights

Daytime sleepiness and difficulty falling asleep are linked to an increased risk of hypertension, according to research reported by Respiratory Therapy on June 16, 2026. These sleep disturbances may serve as clinical markers for cardiovascular strain or underlying respiratory conditions, such as pulmonary hypertension, which can elevate systemic blood pressure.

The findings suggest that both ends of the sleep dysfunction spectrum—insomnia and hypersomnia—correlate with higher blood pressure readings. This connection indicates that erratic sleep patterns are not merely symptoms of poor hygiene but may be physiological indicators of vascular resistance.

How do sleep disturbances affect blood pressure?

Difficulty falling asleep and excessive daytime sleepiness trigger a state of chronic autonomic imbalance. According to Respiratory Therapy, these patterns often reflect an overactive sympathetic nervous system, which keeps the body in a state of heightened arousal.

This arousal increases the release of catecholamines, such as adrenaline, which constrict blood vessels and raise heart rates. When this process occurs consistently, the body fails to achieve the “nocturnal dip,” a natural drop in blood pressure that typically occurs during deep sleep.

The absence of this dip puts continuous pressure on arterial walls. Over time, this leads to permanent hypertension and increases the risk of stroke or myocardial infarction.

What is the link between pulmonary hypertension and sleep?

The research highlights a specific connection between sleep quality and pulmonary hypertension, including Chronic Thromboembolic Pulmonary Hypertension (CTEPH) and Pulmonary Arterial Hypertension (PAH). These conditions involve high blood pressure in the arteries of the lungs.

Patients with pulmonary hypertension often experience severe daytime sleepiness due to nocturnal hypoxia, where oxygen levels in the blood drop during sleep. This hypoxia triggers the brain to wake the patient up or prevents them from entering deep REM stages, leading to fragmented sleep.

According to the reporting, this cycle creates a feedback loop. Poor oxygenation causes sleep fragmentation, and the resulting stress on the heart further exacerbates systemic hypertension.

How does this differ from obstructive sleep apnea?

While Obstructive Sleep Apnea (OSA) is a well-known cause of hypertension, these findings broaden the scope of risk. OSA is characterized by physical airway blockage, but the linked research suggests that sleep disturbances independent of apnea can still predict hypertensive trends.

A comparison of these conditions shows distinct drivers:

• Obstructive Sleep Apnea: Physical collapse of the throat leads to apnea and sudden blood pressure spikes.
• Insomnia/Hypersomnia: Neurological or systemic dysfunction leads to chronic sympathetic activation and steady blood pressure elevation.
• Pulmonary Hypertension: Lung vascular resistance causes low oxygen levels, leading to fragmented sleep and systemic strain.

By identifying daytime sleepiness as a marker for hypertension, clinicians can screen for cardiovascular issues in patients who do not fit the traditional profile of sleep apnea, such as those without obesity or narrow airways.

What are the clinical implications for patients?

The correlation between sleep and blood pressure means that treating the sleep disorder may be a necessary component of managing hypertension. If the hypertension is driven by pulmonary issues like CTEPH, standard blood pressure medication may not address the root cause.

Respiratory Therapy notes that identifying these patterns early allows for earlier intervention in pulmonary vascular disease. This is critical because pulmonary hypertension is often underdiagnosed until it reaches advanced stages of heart failure.

Medical professionals are encouraged to view excessive daytime sleepiness as a potential red flag for cardiovascular health rather than a simple lifestyle issue.

What remains uncertain in the research?

The current data establishes a correlation, but it does not definitively prove that sleep disturbances cause hypertension in all cases. It remains unclear if the sleep issues are a direct cause of the high blood pressure or if both are symptoms of a third, underlying condition like chronic kidney disease or endocrine dysfunction.

Future longitudinal studies are required to determine if improving sleep quality through targeted therapy directly lowers systemic blood pressure in patients with pulmonary hypertension. Until then, the findings serve as a tool for risk stratification and early screening.